| Literature DB >> 26645344 |
Yeon Soo Chung1, Jae Won Song1, Dae Ho Kim1, Sook Shin1, Young Kyung Park1, Soo Jin Yang2, Suk Kyung Lim3, Kun Taek Park1, Yong Ho Park1.
Abstract
Limited information is available regarding horse-associated antimicrobial resistant (AR) Escherichia (E.) coli. This study was designed to evaluate the frequency and characterize the pattern of AR E. coli from healthy horse-associated samples. A total of 143 E. coli (4.6%) were isolated from 3,078 samples collected from three national racetracks and 14 private horse-riding courses in Korea. Thirty of the E. coli isolates (21%) showed antimicrobial resistance to at least one antimicrobial agent, and four of the AR E. coli (13.3%) were defined as multi-drug resistance. Most of the AR E. coli harbored AR genes corresponding to their antimicrobial resistance phenotypes. Four of the AR E. coli carried class 1 integrase gene (intI1), a gene associated with multi-drug resistance. Pulsed-field gel electrophoretic analysis showed no genetic relatedness among AR E. coli isolated from different facilities; however, cross-transmissions between horses or horses and environments were detected in two facilities. Although cross-transmission of AR E. coli in horses and their environments was generally low, our study suggests a risk of transmission of AR bacteria between horses and humans. Further studies are needed to evaluate the risk of possible transmission of horse-associated AR bacteria to human communities through horse riders and horse-care workers.Entities:
Keywords: Escherichia coli; antimicrobial resistance; class 1 integron; cross-transmission; horse
Mesh:
Substances:
Year: 2016 PMID: 26645344 PMCID: PMC4921668 DOI: 10.4142/jvs.2016.17.2.199
Source DB: PubMed Journal: J Vet Sci ISSN: 1229-845X Impact factor: 1.672
Prevalence of Escherichia (E.) coli isolates from horse and environmental samples
Antimicrobial resistance (AR) profiling of E. coli isolated from different samples
*,†A total of 30 isolates (21%) were defined as AR E. coli from horses (n = 25; 13 from feces, 6 from skins and 6 from nasal cavities, respectively) and environmental samples (n = 5; 2 from drinking water and 3 from bedding, respectively). Note that AR E. coli showing resistance to more than one antimicrobial agent were redundantly counted in each antimicrobial resistant test. AM, ampicillin; AMC, amoxicillin/clavulanic acid; GM, gentamicin; TE, tetracycline; SXT, sulfamethoxazole/trimethoprim; ATM, aztreonam; S, streptomycin; CTT, cefotetan; MDR, multi-drug resistance.
Detection of the antimicrobial resistance genes related to AR phenotypes
SHV and TEM, ampicillin resistance genes; strA-B and aadA, streptomycin resistance genes; tetA and tetB, tetracycline resistance genes; sul1, sulfamethoxazole resistance gene; dfrA1/A9/A7/A17/A12/A13, trimethoprim resistance genes.
Characterization of 4 E. coli isolates harboring integrase gene
Fig. 1Pulsed-field gel electrophoresis (PFGE) analysis of antimicrobial-resistant E. coli isolates. All the genomic DNA samples were digested with XbaI followed by standard PFGE analysis (see Materials and Methods). Levels of similarity were determined using Dice coefficient (0.5% optimization, 1.0% tolerance) and the un-weighted pair group method. Individual PFGE patterns are summarized with their isolate ID, antimicrobial resistance profiles, sample sources and PFGE types. *Identification number of each E. coli isolate was given as the serial number of the sampling facility followed by the isolate number in the facility. †Antimicrobial- resistance profiles. ‡Reference strain for PFGE analysis. §Not resistant to any tested antimicrobials. TE, tetracycline; SXT, sulfamethoxazole/trimethoprim; AMC, amoxicillin/clavulanic acid; AM, ampicillin; CTT, cefotetan; S, streptomycin; GM, gentamicin; ATM, aztreonam.